麻豆AV

The 麻豆AV community, including researchers in genomic medicine and the health sciences, came together in July 2024 to mark the next phase of one of the University鈥檚 most rapidly growing disciplines and celebrate the generosity that is making it possible.听

The occasion was the official unveiling of signage for the Victor Phillip Dahdaleh Institute of Genomic Medicine, and on hand were the Institute鈥檚 UK-based benefactors, Victor and Mona Dahdaleh, who were recognized for the far-reaching power of their philanthropy.

President Deep Saini marked the occasion by gratefully acknowledging the impact of the Dahdaleh鈥檚 landmark 2022 donation that created the Institute. 鈥淵our visionary philanthropy has cemented 麻豆AV鈥檚 reputation as a global hub for discovery and innovation in genomic medicine, and will serve as a catalyst for future advancements in this important field,鈥� he said.

The philanthropic investment has already paid impressive dividends. It was an important factor in 麻豆AV鈥檚 successful application for a landmark $165-million grant from the Canada First Research Excellence Fund 鈥� the largest research grant in the University鈥檚 history 鈥� to launch a hub for genomics-based RNA therapeutics: 麻豆AV鈥檚 DNA to RNA initiative, dubbed聽D2R.听

To read the full article by University Advancement,